This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Flaherty, J. T. Articles by Pitt, B. Search for Related Content PubMed PubMed Citation Articles by Flaherty, J. T. Articles by Pitt, B. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Heart Attack Heart Failure Hazardous Substances DB NITROGLYCERIN

Circulation, Vol 51, 132-139, Copyright © 1975 by American Heart Association

ARTICLES

Intravenous nitroglycerin in acute myocardial infarction

JT Flaherty, PR Reid, DT Kelly, DR Taylor, ML Weisfeldt and B Pitt

Vasodilator therapy has been shown to improve ventricular function in patients with left ventricular failure complicating acute myocardial infarction. Sublingual nitroglycerin also improves ventricular function in these patients but its effects are transient and variable. Infusion of intravenous nitroglycerin in 12 patients with acute infarction resulted in a decrease in left ventricular filling pressure from a mean of 22 plus or minus 2 mm Hg to 12 plus or minus 1 mm Hg (P less than 0.001) associated with a 7 mm Hg decrease in mean arterial pressure (P less than 0.05). Since stroke work index did not change significantly, this represents and improvement in ventricular performance and/or an alteration in ventricular compliance. All six patients in whom serial precordial mapping studies were performed showed a decrease in sigma ST (P less than 0.001). These findings suggest that intravenous nitroglycerin improved left ventricular function and decreased the extent of myocardial ischemia. Longer infusion may act to preserve borderline ischemic myocardium and thus limit infarct size.

This article has been cited by other articles:

				N.G. Kounis, G.M. Zavras, P.J. Papadaki, G.D. Soufras, P.J. Vasilakos, E.A. Poulos, M.G. Papadimitriou, and G.V. Gouvelou-Deligianni Interventricular Septal Excursions and Velocities During Experimental Myocardial Ischemia. Effects of Nitroglycerin Infusion Vascular and Endovascular Surgery, May 1, 1991; 25(4): 259 - 266. [Abstract] [PDF]

				N.G. Kounis, G.M. Zavras, G.D. Soufras, P.J. Papadaki, E.A. Poulos, and D.J. Antoniou Left Ventricular Excursions and Velocities During Coronary Arterial Ligation. Effects of Nitroglycerin Infusion in an Experimental Model Angiology, October 1, 1989; 40(10): 899 - 906. [Abstract] [PDF]

				J. T. Flaherty Therapeutic Scope of Intravenous Nitroglycerin Angiology, May 1, 1982; 33(5): 287 - 293. [Abstract] [PDF]

				F. A. Cecena-Seldner and J. Villarreal Effect of the Kallikrein Inhibitor Aprotinin on Myocardial Ischemia and Necrosis in Man Angiology, July 1, 1980; 31(7): 488 - 496. [Abstract] [PDF]

				L. Gould, C.V. Ramana Reddy, S.G. Kim, and K.C. Oh Electrophysiologic Properties of Nitroprusside in Man Angiology, January 1, 1979; 30(12): 841 - 849. [Abstract] [PDF]

				J. A. Franciosa Outflow Resistance as a Regulator of Left Ventricular Performance Angiology, May 1, 1978; 29(5): 393 - 401. [PDF]

				H. H. Wayne Comparison of the Effects of Sustained-Release and Sublingual Nitroglycerine On the Apexcardiogram and Systolic Time Intervals Angiology, March 1, 1977; 28(3): 190 - 202. [PDF]